Joe Gantos’s strategy is well known for it’s emphasis on technical analysis, with particular focus on Japanese Candlestick techniques. Mr. Gantoss uses fundamental analysis and thorough due diligence, to determine the best entry and exit points around clinical and regulatory catalysts.
The founding members of Chimera Research Group have over 50 years of combined experience in the biotech and pharmaceutical sector. Their experience includes work at Investment Banks, Hedge Funds, Pharmaceutical Companies, top-tier Universities, and the FDA. Their published work includes freelance and editorial contributions both print and on-line, clinical and medical research, books and tutorials, as well as contributions to on-line social media. The group’s analysis process is based in the member’s diversity. We employ a multidisciplinary approach, with peer-review of every report to ensure that our subscribers are receiving cutting edge analysis.
Our goal is to give each subscriber, retail or institutional, the most valuable insights and strategies in the biopharmaceutical sector. We strive to provide our subscribers with actionable market intelligence by leveraging the experience, accomplishments and intellectual horsepower of our founding members.
Our Team, Your Consultants
- Hedge Funds
- Venture Capitalists
- Pharmaceutical Executives
- Retail Investors
We provide unparalleled intelligence in the biotech sector, our approach is simple, it is multi-disciplinary and peer-reviewed, so that our clients receive content they can capitalize on.
Are You Ready To Join?